BioSpace News Archive

CNBX Pharmaceuticals Inc. (OTC-QB: CNBX) announced today that the Company’s patent application titled “COMPOSITION AND METHOD FOR TREATING CANCER WITH CANNABINOIDS” was filed on October 12, 2022 with the US Patent and Trademark Office (USPTO) and with the Israel Patent Office under a national phase of International Patent Application.

Pathologists from Europe, Japan and the United States today jointly announced the debut of Digital Pathology Connections (DPC), a global community for professionals interested in the digital future of the anatomic pathology laboratory.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its third quarter 2022 financial results and provide an update on the company’s business and outlook on Thursday, Oct. 27, at 4:30 p.m. ET.

INOVIO today announced positive interim results from an ongoing Phase 1/2 clinical trial evaluating INO-3107 for the treatment of HPV 6 and HPV 11-associated Recurrent Respiratory Papillomatosis (RRP) in adults.

Maze Therapeutics today announced that Harold Bernstein, M.D., Ph.D., a 30-year industry veteran, has been appointed as president, head of research and development (R&D) and chief medical officer.

Bausch Health Companies Inc. will release its third quarter financial results on Thursday, Nov. 3, 2022.

Moderna, Inc. today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 3, 2022 to report its third quarter 2022 financial results, and provide a corporate update.